Posttransplant lymphoproliferative diseases (PTLD)

What are posttransplant lymphoproliferative diseases (PTLD) and the risk factors?

PTLD is a well-recognized complication of the immunosuppression in the kidney transplant patient. Epstein-Barr virus (EBV) is found in two-thirds of PTLD cases. PTLD in kidney transplant patients is mainly a B cell–derived, large cell lymphoma.

Risk factors for PTLD include:

  • • Degree of immunosuppression such as the use of lymphocyte-depleting agents
  • • Transplantation between EBV-positive donor and EBV-negative recipient
  • • <25-year-old recipient
  • • Pretransplant malignancy
  • • PTLD occurs in 0.6% to 1.5% of patients after kidney transplantation, with the majority in the first year

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top